Adoptive transfer of functional SARS-COV-2-specific immunity from donor graft to hematopoietic stem cell transplant recipients.

Autor: La Rosa C; Department of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA., Chiuppesi F; Department of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA., Park Y; Department of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA., Gendzekhadze K; Department of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA., Zhou Q; Department of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA., Faircloth K; Department of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA., Kaltcheva T; Department of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA., Johnson D; Department of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA., Ortega Francisco S; Department of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA., Amanam I; Department of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA., Otoukesh S; Department of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA., Pullarkat VA; Department of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA., Nakamura R; Department of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA., Diamond DJ; Department of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA., Forman SJ; Department of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA., Al Malki MM; Department of Hematology and Hematopoietic Cell Transplantation, 2Histocompatibility Laboratory, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California, USA.
Jazyk: angličtina
Zdroj: American journal of hematology [Am J Hematol] 2022 Nov; Vol. 97 (11), pp. E404-E407. Date of Electronic Publication: 2022 Sep 02.
DOI: 10.1002/ajh.26691
Databáze: MEDLINE